Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial

PURPOSE: To evaluate ocular comfort of lifitegrast ophthalmic solution 5.0% among patients with dry eye disease (DED) in the OPUS-3 trial. METHODS: OPUS-3 was a multicenter, randomized, double-masked, placebo-controlled study. Adults with DED and recent artificial tear use were randomized 1:1 (lifit...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Ophthalmol
Autors principals: Nichols, Kelly K, Holland, Edward, Toyos, Melissa M, Peace, James H, Majmudar, Parag, Raychaudhuri, Aparna, Hamdani, Mohamed, Roy, Monica, Shojaei, Amir
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2018
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5798562/
https://ncbi.nlm.nih.gov/pubmed/29440868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S152841
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars